MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Augmenix Inc., Waltham, Mass.
Augmenix is developing a hydrogel product to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer.
Amar Sawhney, President & CEO
Brad Poff, GM
Jim Fortune, COO